<Record><identifier xmlns="http://purl.org/dc/elements/1.1/">URN:NBN:SI:doc-XR2W92EW</identifier><date>2024</date><creator>Kolenc, Petra</creator><creator>Krošelj, Marko</creator><creator>Novak, Doroteja</creator><relation>documents/doc/X/URN_NBN_SI_doc-XR2W92EW_001.pdf</relation><relation>documents/doc/X/URN_NBN_SI_doc-XR2W92EW_001.txt</relation><format format_type="issue">2</format><format format_type="volume">75</format><format format_type="type">article</format><format format_type="extent">str. 83-93</format><identifier identifier_type="ISSN">0014-8229</identifier><identifier identifier_type="COBISSID_HOST">196302339</identifier><identifier identifier_type="URN">URN:NBN:SI:doc-XR2W92EW</identifier><language>slv</language><publisher publisher_location="Ljubljana">Slovensko farmacevtsko društvo</publisher><source>Farmacevtski vestnik</source><rights>InC</rights><subject language_type_id="slv">ciljano radionuklidno zdravljenje</subject><subject language_type_id="eng">nuclear medicine</subject><subject language_type_id="slv">Nuklearna medicina</subject><subject language_type_id="eng">radioactivity</subject><subject language_type_id="slv">radioaktivnost</subject><subject language_type_id="slv">Radiofarmacija</subject><subject language_type_id="slv">radiofarmaki</subject><subject language_type_id="eng">radiopharmaceuticals</subject><subject language_type_id="eng">targeted radionuclide therapy</subject><subject language_type_id="slv">teranostika</subject><subject language_type_id="eng">theranostic</subject><title>Radiofarmaki v teranostiki</title><title>Theranostic radiopharmaceuticals</title></Record>